Citation Impact
Citing Papers
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
2003 Standout
Tough adhesives for diverse wet surfaces
2017 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
2011 Standout
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Homocysteine and vascular disease
1999 Standout
Gastric cancer
2016 Standout
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
1999
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
2005
Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma
1993
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Cisplatin resistance in human cancers
1991
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
2001 Standout
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.
1989
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
1997
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
1997
Classification of papillomaviruses
2004 StandoutNobel
The resurgence of platinum-based cancer chemotherapy
2007 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Remethylation defects: guidelines for clinical diagnosis and treatment
1998
Uric Acid and Cardiovascular Risk
2008 Standout
Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival.
1997
Esophageal Cancer
2003 Standout
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Neural-Tube Defects
1999 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Susceptibility to spina bifida; an association study of five candidate genes
1998
Colorectal cancer
2013 Standout
Gout
2009 Standout
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
Cancer immunoediting from immune surveillance to immune escape
2007
Homocysteine and cardiovascular disease: cause or effect?
2000
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
1995 Standout
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
1994
T Cells and Stromal Fibroblasts in Human Tumor Microenvironments Represent Potential Therapeutic Targets
2010
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
1997
Homocysteine and Risk of Ischemic Heart Disease and Stroke
2002 Standout
How regulatory T cells work
2008 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
2005
Papillomavirus and HPV typing
1997
Sickle-cell disease
2010 Standout
Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma
1994
Targeting gene expression to hypoxic tumor cells
1997 StandoutNobel
Head and Neck Cancer
1993 Standout
Hyperhomocysteinemia as a risk factor for stroke
1992
Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
1996 StandoutNobel
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
2000 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
1989
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer)
1991
Improved Survival with Neoadjuvant Therapy and Resection for Adenocarcinoma of the Esophagus
1993
Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.
1997
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and Neck
1990
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
2003 Standout
Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.
1991
Etiology of stroke in children
2000
Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.
1989
Enhancement of 5-fluorouracil's anticancer activity by dipyridamole
1989
Pulmonary Complications of Sickle Cell Disease
2012
Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer.
1987
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
2009 Standout
Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial
2003
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
2007
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803
2004
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Fibrin Sealant Adhesive Systems: A Review of Their Chemistry, Material Properties and Clinical Applications
1993
Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus
1998
Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.
1996
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Chemotherapy for the Treatment of Patients with Metastatic Colorectal Cancer: An Overview
1997
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
2000
De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report
2002
Serum Uric Acid Level and Risk for Peripheral Arterial Disease: Analysis of Data From the Multiple Risk Factor Intervention Trial
2007
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
2003 Standout
Homocysteine and Cardiovascular Disease
1998 Standout
Production of TCII (vitamin B12 transport protein) by mouse mononuclear phagocytes
1978
Secretory products of macrophages.
1987 Standout
Follicular Lymphoma Intratumoral CD4+CD25+GITR+ Regulatory T Cells Potently Suppress CD3/CD28-Costimulated Autologous and Allogeneic CD8+CD25− and CD4+CD25− T Cells
2007
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer
2002
Works of J Marquet being referenced
Comparative effect of 6S, 6R and 6RS Leucovorin on methotrexate rescue and on modulation of 5-fluorouracil
1991
A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines
1989
CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.
1998
Methylenetetrahydrofolate reductase deficiency: Prenatal diagnosis and family studies
1994
Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency
1999
Maternal-Fetal Folate Status and Neural Tube Defects: A Case Control Study
1995
Keratinization of middle ear cholesteatomas
1990
5-Fluorourcil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma
1993
The Three Transcobalamins in Myeloproliferative Disorders and Acute Leukaemia
1975
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
1986
Fibrin glue in tympanoplasty.
1985
Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
1985
Fluorouracil Combined With the Pure (6S)-Stereoisomer of Folinic Acid in High Doses for Treatment of Patients With Advanced Colorectal Carcinoma: A Phase I-II Study
1992
Homocystinuria due to 5,10‐methylenetetra‐hydrofolate reductase deficiency revealed by stroke in adult siblings
1991